Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saverio Alberti

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Trends in Biotechnology|August 15, 2006
The forgotten variables of DNA array hybridizationErminia Carletti, Emanuela Guerra, Saverio Alberti
Anticancer Research|August 5, 2010
(-)-Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cellsMugdha Sukhthankar, Saverio Alberti, Seung Joon Baek
Nucleic Acids Research|February 13, 2003
Detection and analysis of spliced chimeric mRNAs in sequence databanksAntonello Romani, Emanuela Guerra, Marco Trerotola, et al.
Human Genomics|July 29, 2015
Epigenetic inheritance and the missing heritabilityMarco Trerotola, Valeria Relli, Pasquale Simeone, et al.
Trends in Molecular Medicine|June 4, 2019
Abandoning the Notion of Non-Small Cell Lung CancerValeria Relli, Marco Trerotola, Emanuela Guerra, et al.
Oncotarget|November 27, 2018
Distinct lung cancer subtypes associate to distinct drivers of tumor progressionValeria Relli, Marco Trerotola, Emanuela Guerra, et al.
Journal of Cellular Physiology|March 2, 2012
Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axisMarco Trerotola, Jing Li, Saverio Alberti, et al.
FEBS Letters|August 7, 2002
Oligomerization of DsRed is required for the generation of a functional red fluorescent chromophoreAndrea Sacchetti, Vinod Subramaniam, Thomas M Jovin, et al.
Frontiers in Oncology|July 17, 2023
A non-mutated <i>TROP2</i> fingerprint in cancer geneticsEmanuela Guerra, Roberta Di Pietro, Gianmarco Stati, et al.
International Journal of Cancer|September 5, 2002
Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cellsGiorgio Mangino, Maria Grazia Capri, Vincenzo Barnaba, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Trends in Biotechnology|August 15, 2006
The forgotten variables of DNA array hybridizationErminia Carletti, Emanuela Guerra, Saverio Alberti
Anticancer Research|August 5, 2010
(-)-Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cellsMugdha Sukhthankar, Saverio Alberti, Seung Joon Baek
Nucleic Acids Research|February 13, 2003
Detection and analysis of spliced chimeric mRNAs in sequence databanksAntonello Romani, Emanuela Guerra, Marco Trerotola, et al.
Human Genomics|July 29, 2015
Epigenetic inheritance and the missing heritabilityMarco Trerotola, Valeria Relli, Pasquale Simeone, et al.
Trends in Molecular Medicine|June 4, 2019
Abandoning the Notion of Non-Small Cell Lung CancerValeria Relli, Marco Trerotola, Emanuela Guerra, et al.
Oncotarget|November 27, 2018
Distinct lung cancer subtypes associate to distinct drivers of tumor progressionValeria Relli, Marco Trerotola, Emanuela Guerra, et al.
Journal of Cellular Physiology|March 2, 2012
Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axisMarco Trerotola, Jing Li, Saverio Alberti, et al.
FEBS Letters|August 7, 2002
Oligomerization of DsRed is required for the generation of a functional red fluorescent chromophoreAndrea Sacchetti, Vinod Subramaniam, Thomas M Jovin, et al.
Frontiers in Oncology|July 17, 2023
A non-mutated <i>TROP2</i> fingerprint in cancer geneticsEmanuela Guerra, Roberta Di Pietro, Gianmarco Stati, et al.
International Journal of Cancer|September 5, 2002
Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cellsGiorgio Mangino, Maria Grazia Capri, Vincenzo Barnaba, et al.
Pageof 7